相关实验视频
Updated: Jun 28, 2025

08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
67.2K
增长分化因子-15血清度反映了炎症性肠病患者的疾病严重程度和贫血
Ante Tonkic1, Marko Kumric2, Ivna Akrapovic Olic3
1Biology of Neoplasms, University of Split School of Medicine, Split 21000, Croatia.
World journal of gastroenterology
|April 25, 2024
概括
与健康个体相比,炎症性肠病 (IBD) 患者的生长差异化因子-15 (GDF-15) 的血清度显著增加. 这些高的GDF-15水平与IBD患者的疾病严重程度和贫血相关.
科学领域:
- 胃肠道学和免疫学
- 生物标志物发现发现
- 炎症性肠道疾病研究研究
背景情况:
- 炎症性肠病 (IBD) 患者由于肠外表现而经历显著的发病率.
- 增长差异化因子-15 (GDF-15) 是一种因压力而产生的蛋白质,与各种疾病有关.
研究的目的:
- 调查血清GDF-15水平与IBD之间的关联.
- 确定GDF-15是否预测IBD患者的结果,并与IBD患者的临床参数相关.
主要方法:
- 对90名IBD患者 (克罗恩病和性结肠炎) 和67名对照者的横截面研究.
- 使用临床和内镜评分评估疾病活动.
- 通过电化学发光免疫测试测量血清GDF-15.
主要成果:
- 患有IBD的患者显示GDF-15血清度明显高于对照组 (P < 0.001).
- GDF-15水平独立预测了IBD严重程度,并与贫血和血清铁水平较低有关.
- 克罗恩病和性结肠炎之间没有观察到GDF-15的显著差异.
结论:
- 血清GDF-15在IBD患者中升高,这表明它在疾病病理生理学中起着作用.
- 需要进一步的研究来确定GDF-15作为IBD的预后标志物.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Inflammatory Bowel Disease II: Crohn's Disease
222
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
222
Inflammatory Bowel Disease I: Ulcerative Colitis
172
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
172
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
160
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
160

